ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
36Kr/KrASIA

Chinese maker of 3D-printed drugs secures $15m in funding

Startup Triastek has already filed patent applications in Japan and the US

Triastek develops 3D-printed medicines and their production facilities. (Photo courtesy of Triastek)

BEIJING -- Triastek, a Chinese startup using 3D technology to develop medicines, has raised about 100 million yuan ($15 million) in a Series A+ funding round.

The lead investor is Dalton Venture, while the co-investors are Shanghai Tofflon Science and Technology Chairman Zheng Xiaodong and Yunqi Partners.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more